Updated Jul 16, 2026
Lu Timothy K is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Timothy K. Lu is a prominent figure in the biotechnology sector, known for his role as the CEO of Senti Biosciences, Inc. He has a background in engineering and medicine, with a focus on synthetic biology and gene therapy. Lu has contributed to advancements in the field through both his academic work and leadership in the biotech industry.
| Role | CEO, Director |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-11 | SNTI | Senti Biosciences, Inc. | F — Tax withholding / forfeiture | 80.7K | $0.00 | |
| 2026-02-03 | SNTI | Senti Biosciences, Inc. | F — Tax withholding / forfeiture | 4.2K | $0.00 |
Timothy K. Lu is a prominent figure in the biotechnology sector, known for his role as the CEO of Senti Biosciences, Inc. He has a background in engineering and medicine, with a focus on synthetic biology and gene therapy. Lu has contributed to advancements in the field through both his academic work and leadership in the biotech industry.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lu Timothy K profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.